Company / Operating Margin
4D Molecular Therapeutics, Inc. Operating Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-507678.4%
FY2025
5-year range
-507678.4% / -395.5%
FY2021-FY2025
Trend
-93111.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -93112% YoY in FY2025, a notable deviation from the 5-year average annual change of -18754%.
Based on SEC 10-K filings.
-507678.4% in FY2025 with a 5-year CAGR of -506951.7%.
Declined from -3516.5% to -507678.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -507282.9pp
- 5-Year Change
- -506951.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 93111.9% year-over-year.
- Peak operating margin was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -507678.4% | -93111.9% |
| FY2024 | -544.7% | +84.5% |
| FY2023 | -3516.5% | -789.2% |
| FY2022 | -395.5% | +5.0% |
| FY2021 | -416.3% | +42.7% |
| FY2020 | -726.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026